SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-020146
Filing Date
2024-02-26
Accepted
2024-02-26 16:08:13
Documents
13
Period of Report
2024-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-20240226.htm   iXBRL 8-K 40490
2 EX-99.1 fgen-ex99_1.htm EX-99.1 242275
  Complete submission text file 0000950170-24-020146.txt   407322

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fgen-20240226.xsd EX-101.SCH 23887
14 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20240226_htm.xml XML 4509
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 24678736
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)